13.67
+0.26(+1.94%)
Currency In USD
| Previous Close | 13.41 |
| Open | 13.02 |
| Day High | 13.84 |
| Day Low | 12.8 |
| 52-Week High | 1,184 |
| 52-Week Low | 6.76 |
| Volume | 229,414 |
| Average Volume | 2M |
| Market Cap | 76.42M |
| PE | 0 |
| EPS | -8,039 |
| Moving Average 50 Days | 20.88 |
| Moving Average 200 Days | 60.11 |
| Change | 0.26 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of March 13, 2025 at a share price of $13.67. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.03 as of March 13, 2025 at a share price of $13.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
GlobeNewswire Inc.
7 hours ago
CHATHAM, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announc
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
GlobeNewswire Inc.
Mar 11, 2025 11:00 AM GMT
CHATHAM, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman M
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
GlobeNewswire Inc.
Mar 10, 2025 12:00 PM GMT
The World Health Organization (WHO) recently reaffirmed the spread of new clade Ib Mpox a public health emergency of international concern (PHEIC): second Mpox-related WHO PHEIC declaration in two years Clade Ib Mpox cases detected in several countri